retatrutide study near me STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD and Obesity A Study of Retatrutide (LY3437943)
Description
The Lancet , 397 (10286), 1736-1748
4.2.1 GLP-1 RAs and AD AD is characterized by the deficits in cognition, memory, and learning
Findings Patient volumes for the drugs included in the analysis have increased substantially quarter-over-quarter, some of which are correlated with FDA approval timelines
Approval requires review of evidence on quality, safety, and effectiveness for specific uses
Studies in knock-out mice confirmed the biological action of [dA(2)]GLP-1/GcG which is related to its ability to target GIP, GLP-1, and glucagon receptors
2011;17:BR3541
